Stocks and Investing Stocks and Investing
Tue, August 8, 2017
Mon, August 7, 2017

David Risinger Downgraded (TEVA) to Sell and Held Target at $16 on, Aug 7th, 2017


Published on 2024-10-25 22:09:03 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell and Held Target at $16 on, Aug 7th, 2017.

David has made no other calls on TEVA in the last 4 months.



There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 6 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Vamil Divan of "Credit Suisse" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
  • Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
  • Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017


This is the rating of the analyst that currently disagrees with David


  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017

Contributing Sources